FRASSINE, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 101
EU - Europa 84
AS - Asia 43
Totale 228
Nazione #
US - Stati Uniti d'America 100
IT - Italia 48
CN - Cina 15
SG - Singapore 12
DE - Germania 9
FI - Finlandia 7
HK - Hong Kong 6
GB - Regno Unito 5
TR - Turchia 5
IE - Irlanda 4
UA - Ucraina 4
VN - Vietnam 4
PL - Polonia 2
BE - Belgio 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
JM - Giamaica 1
NL - Olanda 1
RU - Federazione Russa 1
SE - Svezia 1
Totale 228
Città #
Brescia 18
Ashburn 14
Fairfield 12
Singapore 12
Cambridge 8
New York 8
Milan 7
Chandler 6
Helsinki 6
Hong Kong 6
Wilmington 6
Beijing 5
Woodbridge 5
Dong Ket 4
Dublin 4
Houston 4
Istanbul 4
Jacksonville 4
Lumezzane 4
Munich 4
Seattle 4
Washington 3
Boardman 2
Dearborn 2
Princeton 2
Rome 2
Romola 2
Shanghai 2
Warsaw 2
Ann Arbor 1
Brno 1
Brussels 1
Changsha 1
Groningen 1
Guangzhou 1
Hebei 1
Hefei 1
Hounslow 1
Jakarta 1
Jinan 1
Kilburn 1
Lappeenranta 1
Leipzig 1
Los Angeles 1
San Francisco 1
Stockholm 1
Taranto 1
Totale 180
Nome #
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 124
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 54
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 47
SBRT in Lymph-Nodal Oligometastases from Prostate Cancer: Different Outcomes between Pelvic and Para-Aortic Disease 9
Totale 234
Categoria #
all - tutte 1.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.474


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 0 0 0 0 10 9 8 7 4 2 1
2020/202139 2 1 8 1 1 7 0 3 2 6 4 4
2021/20229 2 0 0 0 0 1 0 0 1 2 0 3
2022/202353 1 1 1 1 2 15 7 6 3 1 14 1
2023/202458 1 0 9 2 4 14 4 0 8 3 2 11
2024/202534 1 2 3 19 9 0 0 0 0 0 0 0
Totale 234